DCLRE1C operates in the DNA double-strand break repair pathway, defect of which has been strongly associated with breast cancer predisposition [11], and ITGA9 encodes α-integrin, which participates in the control of cell division, differentiation and migration [12–14]. Here, ITGA9 is linked to breast carcinoma.